Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Clemens Honeder is active.

Publication


Featured researches published by Clemens Honeder.


Ear and Hearing | 2014

FS4, FS4-p, and FSP: a 4-month crossover study of 3 fine structure sound-coding strategies.

Dominik Riss; Jafar-Sasan Hamzavi; Michaela Blineder; Clemens Honeder; Isabella Ehrenreich; Alexandra Kaider; Wolf-Dieter Baumgartner; Wolfgang Gstoettner; Christoph Arnoldner

Objectives: The aim of the present study was to compare two novel fine structure strategies “FS4” and “FS4-p” with the established fine structure processing (FSP) strategy. FS4 provides fine structure information on the apical four-electrode channels. With FS4-p, these electrodes may be stimulated in a parallel manner. The authors evaluated speech perception, sound quality, and subjective preference. Design: A longitudinal crossover study was done on postlingually deafened adults (N = 33) who were using FSP as their default strategy. Each participant was fitted with FS4, FS4-p, and FSP, for 4 months in a randomized and blinded order. After each run, an Adaptive Sentence test in noise (Oldenburger Sentence Test [OLSA]) and a Monosyllable test in quiet (Freiburger Monosyllables) were performed, and subjective sound quality was determined with a Visual Analogue Scale. At the end of the study the preferred strategy was noted. Results: Scores of the OLSA did not reveal any significant differences among the three strategies, but the Freiburger test showed a statistically significant effect (p = 0.03) with slightly worse scores for FS4 (49.7%) compared with FSP (54.3%). Performance of FS4-p (51.8%) was comparable with the other strategies. Both audiometric tests depicted a high variability among subjects. The number of best-performing strategies for each participant individually was as follows: (a) for the OLSA: FSP, N = 10.5; FS4, N = 10.5; and FS4-p, N = 12; and (b) for the Freiburger test: FSP, N = 14; FS4, N = 9; and FS4-p, N = 10. A moderate agreement was found in the best-performing strategies of the Speech tests within the participants. For sound quality, speech in quiet, classical, and pop music were assessed. No significant effects of strategy were found for speech in quiet and classical music, but auditory impression of pop music was rated as more natural in FSP compared with FS4 (p = 0.04). It is interesting that at the end of the study, a majority of the participants favored the new coding strategies over their previous default FSP (FSP, N = 13; FS4, N = 13; FS4-p, N = 7). Conclusions: In summary, FS4 and FS4-p offer new and further options in audio processor fitting, with similar levels of speech understanding in noise as FSP. This is an interesting result, given that the strategies’ presentation of temporal fine structure differs from FSP. At the end of the study, 20 of 33 subjects chose either FS4 or FS4-p over their previous default strategy FSP.


International Journal of Pharmaceutics | 2014

Preclinical evaluation of thermoreversible triamcinolone acetonide hydrogels for drug delivery to the inner ear

Elisabeth Engleder; Clemens Honeder; Julia Klobasa; Michael Wirth; Christoph Arnoldner; Franz Gabor

Graphical abstract


Audiology and Neuro-otology | 2014

Sustained release of triamcinolone acetonide from an intratympanically applied hydrogel designed for the delivery of high glucocorticoid doses.

Clemens Honeder; Elisabeth Engleder; Hanna Schöpper; Franz Gabor; Gottfried Reznicek; Jens Wagenblast; Wolfgang Gstoettner; Christoph Arnoldner

The pharmacokinetic properties and tolerability of a triamcinolone acetonide poloxamer 407 hydrogel for intratympanic application were investigated in a guinea pig model. Evaluation of in vivo release kinetics showed very high initial perilymph drug levels, with clinically relevant levels present for a minimum of 10 days. Assessment of auditory brainstem response thresholds showed a minimal, delayed and transient threshold shift, which was apparent on day 3 and resolved by day 10. No relevant histological changes of the middle and inner ear structures were noted, and hair cell counts showed no significant differences between treated and untreated ears. Thus, the triamcinolone-acetonide-loaded poloxamer 407 hydrogel is an effective vehicle for sustained high-dose inner ear glucocorticoid delivery.


Human Molecular Genetics | 2010

The nucleotide composition of microsatellites impacts both replication fidelity and mismatch repair in human colorectal cells

Christoph Campregher; Theresa Scharl; Manuela Nemeth; Clemens Honeder; Thomas Jascur; C. Richard Boland; Christoph Gasche

Microsatellite instability is a key mechanism of colon carcinogenesis. We have previously studied mutations within a (CA)13 microsatellite using an enhanced green fluorescent protein (EGFP)-based reporter assay that allows the distinction of replication errors and mismatch repair (MMR) activity. Here we utilize this assay to compare mutations of mono- and dinucleotide repeats in human colorectal cells. HCT116 and HCT116+chr3 cells were stably transfected with EGFP-based plasmids harboring A10, G10, G16, (CA)13 and (CA)26 repeats. EGFP-positive mutant fractions were quantitated by flow cytometry, mutation rates were calculated and the mutant spectrum was analyzed by cycle sequencing. EGFP fluorescence pattern changed with the microsatellites nucleotide sequence and cell type and clonal variations were observed in mononucleotide repeats. Replication errors (as calculated in HCT116) at A10 repeats were 5–10-fold higher than in G10, G16 were 30-fold higher than G10 and (CA)26 were 10-fold higher than (CA)13. The mutation rates in hMLH1-proficient HCT116+chr3 were 30–230-fold lower than in HCT116. MMR was more efficient in G16 than in A10 clones leading to a higher stability of poly-G tracts. Mutation spectra revealed predominantly 1-unit deletions in A10, (CA)13 and G10 and 2-unit deletions or 1-unit insertion in (CA)26. These findings indicate that both replication fidelity and MMR are affected by the microsatellites nucleotide composition.


Clinical Cancer Research | 2010

Mesalazine Reduces Mutations in Transforming Growth Factor β Receptor II and Activin Type II Receptor by Improvement of Replication Fidelity in Mononucleotide Repeats

Christoph Campregher; Clemens Honeder; Heekyung Chung; John M. Carethers; Christoph Gasche

Purpose: Mesalazine (5-aminosalicylic acid, 5-ASA) has chemopreventive properties in colitis-associated cancer. In vitro, it improves replication fidelity at (CA)13 microsatellites independent of mismatch repair proficiency. Therefore, 5-ASA might be advantageous in patients with hereditary nonpolyposis colorectal cancer. At this point, however, it is uncertain whether this improvement of replication fidelity is specific for (CA)13 repetitive sequences. Here, we tested the effect of 5-ASA on replication fidelity in mononucleotide, dinucleotide, and tetranucleotide repeats. Experimental Design: HCT116 and HCT116+chr3 cells were transfected with pIREShyg2-EGFP reporter plasmids harboring the following microsatellites: A10, G10, (CA)13, (CA)26, (AAAG)17, poly-A tracts, and their flanking sequences of transforming growth factor β receptor II (TGFBR2; A10) and activin type II receptor (ACVR2; A8). Stably transfected single-cell clones were selected, characterized by Southern blotting, sorted into six-well plates, and cultured with or without 5-ASA. Frameshift mutations that shift the enhanced green fluorescence protein into its proper reading frame were quantified by flow cytometry. Results: In HCT116, 5-ASA reduced the mutant fraction at (CA)13 by 48.3%, at A10 by 35.6-43.6%, at G10 by 74.9-83.6%, and at (AAAG)17 by 37.6-44.4%. Similar results were observed in hMLH1-proficient HCT116+chr3 cells. Moreover, the presence of 5-ASA significantly reduced mutations in TGFBR2 (A10) and ACVR2 (A8) by 39.9% and 46.2%, respectively. Conclusions: 5-ASA increases replication fidelity in mononucleotide, dinucleotide, and tetranucleotide repeats and reduces mutations in tumor suppressor genes TGFBR2 and ACVR2, a finding that may provoke in vivo studies for the prevention of colorectal cancer in hereditary nonpolyposis colorectal cancer. Clin Cancer Res; 16(6); 1950–6


Laryngoscope | 2014

Ten-year health-related quality of life in cochlear implant recipients: prospective SF-36 data with SF-6D conversion.

Christoph Arnoldner; Vincent Lin; Clemens Honeder; David Shipp; Julian M. Nedzelski; Joseph M. Chen

To evaluate the long‐term impact of cochlear implantation on quality of life measured by the Medical Outcomes Study 36‐Item Short‐Form Health Survey (SF‐36). Scores were also converted to the SF‐6D to derive health utility scores.


Laryngoscope | 2014

Vibroplasty in mixed and conductive hearing loss: comparison of different coupling methods.

Erich Vyskocil; Dominik Riss; Clemens Honeder; Christoph Arnoldner; Jafar-Sasan Hamzavi; Wolf-Dieter Baumgartner; Stefan Flak; Wolfgang Gstoettner

To evaluate modified coupling techniques of the Vibrant Soundbridge system in patients with mixed and conductive hearing loss and to compare it with conventional vibroplasty.


Acta Oto-laryngologica | 2015

Effects of intraoperatively applied glucocorticoid-hydrogels on residual hearing and foreign-body reaction in a guinea pig model of cochlear implantation

Clemens Honeder; Lukas D. Landegger; Elisabeth Engleder; Franz Gabor; Roberto Plasenzotti; Hanns Plenk; Alexandra Kaider; Lena Hirtler; Wolfgang Gstoettner; Christoph Arnoldner

Abstract Conclusion: The intraoperative application of glucocorticoid-loaded hydrogels seems to cause a reduction in neutrophil infiltration. No beneficial effect on hearing thresholds was detected. Objectives: To evaluate the application of dexamethasone- and triamcinolone acetonide-loaded hydrogels for effects on hearing preservation and foreign body reaction in a guinea pig model for cochlear implantation (CI). Methods: A total of 48 guinea pigs (n = 12 per group) were implanted with a single channel electrode and intraoperatively treated with 50 μl of a 20% w/v poloxamer 407 hydrogel loaded with 6% dexamethasone or 30% triamcinolone acetonide, a control hydrogel, or physiological saline. Click- and tone burst-evoked compound action potential thresholds were determined preoperatively and directly postoperatively as well as on days 3, 7, 14, 21, and 28. At the end of the experiment, temporal bones were prepared for histological evaluation by a grinding/polishing technique with the electrode in situ. Three ears per treatment group were serially sectioned and evaluated for histological alterations. Results: The intratympanic application of glucocorticoid-loaded hydrogels did not improve the preservation of residual hearing in this cochlear implant model. The foreign body reaction to the electrode appeared reduced in the glucocorticoid-treated animals. No correlation was found between the histologically described trauma to the inner ear and the resulting hearing threshold shifts.


Clinical Otolaryngology | 2017

Dura and sinus compression with a transcutaneous bone conduction device – hearing outcomes and safety in 38 patients

Erich Vyskocil; Dominik Riss; Christoph Arnoldner; Jafar-Sasan Hamzavi; Rudolfs Liepins; Alexandra Kaider; Clemens Honeder; J. Fumicz; Wolfgang Gstoettner; Wolf-Dieter Baumgartner

In 2011 a bone conduction implant that utilizes electromagnetic signals transmitted through the skin instead of vibrations was introduced onto the market. The implantable portion (the bone conduction floating mass transducer, or BC-FMT) is an electromagnetic transducer that is fixed to the skull bone with screws and delivers mechanical vibrations to the inner ear 1. It is often not possible to place the relatively large BC-FMT (15.8 mm in diameter and 8.7 mm in height) exclusively in the bone of the mastoid. This article is protected by copyright. All rights reserved.


Laryngoscope | 2015

Evaluation of the selective glucocorticoid receptor agonist compound A for ototoxic effects

Clemens Honeder; Elisabeth Engleder; Hanna Schöpper; Markus Krause; Lukas D. Landegger; Roberto Plasenzotti; Franz Gabor; Wolfgang Gstoettner; Christoph Arnoldner

To evaluate the selective glucocorticoid receptor agonist (SEGRA) compound A, a potential novel therapeutic for inner ear disorders, for ototoxic effects.

Collaboration


Dive into the Clemens Honeder's collaboration.

Top Co-Authors

Avatar

Christoph Arnoldner

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Wolfgang Gstoettner

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Dominik Riss

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Alexandra Kaider

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Christoph Campregher

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Christoph Gasche

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Chengjing Zhu

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Hanna Schöpper

University of Veterinary Medicine Vienna

View shared research outputs
Researchain Logo
Decentralizing Knowledge